Literature DB >> 33670631

The Efficacy and Safety of Dual-Frequency Ultrasound for Improving Skin Hydration and Erythema in Patients with Rosacea and Acne.

Young Jae Kim1, Ik Jun Moon1, Hae Woong Lee2, Chong Hyun Won1, Sung Eun Chang1, Mi Woo Lee1, Jee Ho Choi1, Woo Jin Lee1.   

Abstract

Inflammatory skin diseases, such as rosacea and acne, are major causes of facial erythema and accompanying skin barrier dysfunction. Several methods to restore the impaired skin barrier and improve facial erythema, such as medication, radiofrequency, laser, and ultrasound therapy were attempted. This study evaluated the efficacy and safety of dual-frequency ultrasound with impulse mode, for improving skin hydration and erythema in Asian subjects with rosacea and acne. Twenty-six subjects with facial erythema received an ultrasound treatment once per week, for 4 weeks, over both cheeks. The erythema index and transepidermal water loss (TEWL) were measured at each visit. Clinicians assessed the erythema improvement and patients evaluated their satisfaction level. The average decrease in TEWL and erythema index at 6 weeks was 5.37 ± 13.22 g·h-1·m-2 (p = 0.020) and 39.73 ± 44.21 (p = 0.010), respectively. The clinician's erythema assessment and the subject satisfaction questionnaire score significantly improved at final follow-up (p < 0.001; p = 0.003, respectively). No serious adverse effects were observed during the treatment and follow-up periods. The dual-frequency ultrasound with impulse mode appears to be effective and safe for improving skin hydration and erythema in patients with rosacea and acne.

Entities:  

Keywords:  acne; facial erythema; inflammation; rosacea; skin; ultrasound

Year:  2021        PMID: 33670631     DOI: 10.3390/jcm10040834

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  1 in total

1.  Effect of Evening Primrose Oil Supplementation on Selected Parameters of Skin Condition in a Group of Patients Treated with Isotretinoin-A Randomized Double-Blind Trial.

Authors:  Agnieszka Kaźmierska; Izabela Bolesławska; Adriana Polańska; Aleksandra Dańczak-Pazdrowska; Paweł Jagielski; Sławomira Drzymała-Czyż; Zygmunt Adamski; Juliusz Przysławski
Journal:  Nutrients       Date:  2022-07-21       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.